Evidence map›Paper›PMID 22940691›Full record

ArticleThe EMBO journal2012

Endoglin mediates fibronectin/α5β1 integrin and TGF-β pathway crosstalk in endothelial cells.

Hongyu Tian, Karthikeyan Mythreye, Christelle Golzio, Nicholas Katsanis, Gerard C Blobe

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 86 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Promoting collagen synthesis: a viable strategy to combat skin ageing.Journal of enzyme inhibition and medicinal chemistry · 2025
    Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. The BMP Pathway in Blood Vessel and Lymphatic Vessel Biology.International journal of molecular sciences · 2021
    Review
  14. Article
  15. The Role of Endoglin in Hepatocellular Carcinoma.International journal of molecular sciences · 2021
    Review
  16. Endoglin in the Spotlight to Treat Cancer.International journal of molecular sciences · 2021
    Review
  17. Review
  18. The Application of Single-Cell Technologies in Cardiovascular Research.Frontiers in cell and developmental biology · 2021
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Hongyu TianDivision of Medical Oncology, Department of Medicine, Duke University Medical Center, Durham, NC, USA.
Karthikeyan Mythreye
Christelle Golzio
Nicholas Katsanis
Gerard C Blobe
Duke Medical Center · USDuke University · US

Funding

Role of TbRIII in Regulating Motility and InvasionR01CA135006 · NCI · DUKE UNIVERSITY · PI BLOBE, GERARD C · 2009 to 2013
$2.2M
NCI NIH HHS R01 CA135006NCI NIH HHS R01-CA135006
6 · The paper itself

Abstract

Both the transforming growth factor β (TGF-β) and integrin signalling pathways have well-established roles in angiogenesis. However, how these pathways integrate to regulate angiogenesis is unknown. Here, we show that the extracellular matrix component, fibronectin, and its cellular receptor, α5β1 integrin, specifically increase TGF-β1- and BMP-9-induced Smad1/5/8 phosphorylation via the TGF-β superfamily receptors endoglin and activin-like kinase-1 (ALK1). Fibronectin and α5β1 integrin increase Smad1/5/8 signalling by promoting endoglin/ALK1 cell surface complex formation. In a reciprocal manner, TGF-β1 activates α5β1 integrin and downstream signalling to focal adhesion kinase (FAK) in an endoglin-dependent manner. α5β1 integrin and endoglin form a complex on the cell surface and co-internalize, with their internalization regulating α5β1 integrin activation and signalling. Functionally, endoglin-mediated fibronectin/α5β1 integrin and TGF-β pathway crosstalk alter the responses of endothelial cells to TGF-β1, switching TGF-β1 from a promoter to a suppressor of migration, inhibiting TGF-β1-mediated apoptosis to promote capillary stability, and partially mediating developmental angiogenesis in vivo. These studies provide a novel mechanism for the regulation of TGF-β superfamily signalling and endothelial function through crosstalk with integrin signalling pathways.

Indexed as

Activin Receptors, Type IIAntigens, CDApoptosisCell LineCell MovementEndoglinEndothelial CellsFibronectinsFocal Adhesion Protein-Tyrosine KinasesGrowth Differentiation Factor 2Growth Differentiation FactorsHumansIntegrin alpha5beta1MicrovesselsNeovascularization, PhysiologicPhosphorylationActivin Receptors, Type IIACVRL1 protein, humanAntigens, CDEndoglinENG protein, humanFibronectinsFocal Adhesion Protein-Tyrosine KinasesGDF2 protein, humanGrowth Differentiation Factor 2Growth Differentiation FactorsIntegrin alpha5beta1Receptors, Cell SurfaceSmad1 ProteinSMAD1 protein, humanSmad5 ProteinSMAD5 protein, humanSmad8 ProteinSMAD9 protein, humanTransforming Growth Factor beta1

Identifiers

PMID22940691
PMCPMC3463850
OpenAlexW2115352199

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.